168 related articles for article (PubMed ID: 37280675)
1. Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
de Heer EC; Zois CE; Bridges E; van der Vegt B; Sheldon H; Veldman WA; Zwager MC; van der Sluis T; Haider S; Morita T; Baba O; Schröder CP; de Jong S; Harris AL; Jalving M
J Exp Clin Cancer Res; 2023 Jun; 42(1):143. PubMed ID: 37280675
[TBL] [Abstract][Full Text] [Related]
2. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
[TBL] [Abstract][Full Text] [Related]
3. Glycogen Metabolism and Rheumatoid Arthritis: The Role of Glycogen Synthase 1 in Regulation of Synovial Inflammation
Shi M; Wang J; Xiao Y; Wang C; Qiu Q; Lao M; Yu Y; Li Z; Zhang H; Ye Y; Liang L; Yang X; Chen G; Xu H
Front Immunol; 2018; 9():1714. PubMed ID: 30100905
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1.
Pescador N; Villar D; Cifuentes D; Garcia-Rocha M; Ortiz-Barahona A; Vazquez S; Ordoñez A; Cuevas Y; Saez-Morales D; Garcia-Bermejo ML; Landazuri MO; Guinovart J; del Peso L
PLoS One; 2010 Mar; 5(3):e9644. PubMed ID: 20300197
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
6. Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells.
Bhanot H; Reddy MM; Nonami A; Weisberg EL; Bonal D; Kirschmeier PT; Salgia S; Podar K; Galinsky I; Chowdary TK; Neuberg D; Tonon G; Stone RM; Asara J; Griffin JD; Sattler M
Leukemia; 2015 Jul; 29(7):1555-1563. PubMed ID: 25703587
[TBL] [Abstract][Full Text] [Related]
7. LEFTY2/endometrial bleeding-associated factor up-regulates Na+ Coupled Glucose Transporter SGLT1 expression and Glycogen Accumulation in Endometrial Cancer Cells.
Zeng N; Okumura T; Alauddin M; Khozooei S; Rajaxavier J; Zhang S; Singh Y; Shi B; Brucker SY; Wallwiener D; Takeda S; Lang F; Salker MS
PLoS One; 2020; 15(4):e0230044. PubMed ID: 32236143
[TBL] [Abstract][Full Text] [Related]
8. Impaired insulin-stimulated expression of the glycogen synthase gene in skeletal muscle of type 2 diabetic patients is acquired rather than inherited.
Huang X; Vaag A; Hansson M; Weng J; Laurila E; Groop L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1584-90. PubMed ID: 10770201
[TBL] [Abstract][Full Text] [Related]
9. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
10. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
11. CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer.
Black JL; Harrell JC; Leisner TM; Fellmeth MJ; George SD; Reinhold D; Baker NM; Jones CD; Der CJ; Perou CM; Parise LV
Breast Cancer Res Treat; 2015 Jul; 152(2):337-46. PubMed ID: 26105795
[TBL] [Abstract][Full Text] [Related]
12. FGF13 promotes metastasis of triple-negative breast cancer.
Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
[TBL] [Abstract][Full Text] [Related]
13. Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.
Donohue KJ; Fitzsimmons B; Bruntz RC; Markussen KH; Young LEA; Clarke HA; Coburn PT; Griffith LE; Sanders W; Klier J; Burke SN; Maurer AP; Minassian BA; Sun RC; Kordasiewisz HB; Gentry MS
Neurotherapeutics; 2023 Oct; 20(6):1808-1819. PubMed ID: 37700152
[TBL] [Abstract][Full Text] [Related]
14. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
15. Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.
Abbadi S; Rodarte JJ; Abutaleb A; Lavell E; Smith CL; Ruff W; Schiller J; Olivi A; Levchenko A; Guerrero-Cazares H; Quinones-Hinojosa A
Mol Cancer Res; 2014 Nov; 12(11):1547-59. PubMed ID: 25001192
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional characterization of glycogen synthase in the porcine satellite cells under insulin treatment.
Wang L; Xiong Y; Zuo B; Lei M; Ren Z; Xu D
Mol Cell Biochem; 2012 Jan; 360(1-2):169-80. PubMed ID: 21931959
[TBL] [Abstract][Full Text] [Related]
17. Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
Liu CY; Chen KF; Chao TI; Chu PY; Huang CT; Huang TT; Yang HP; Wang WL; Lee CH; Lau KY; Tsai WC; Su JC; Wu CY; Chen MH; Shiau CW; Tseng LM
J Mol Med (Berl); 2017 Sep; 95(9):965-975. PubMed ID: 28578456
[TBL] [Abstract][Full Text] [Related]
18. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.
Li Q; Liu M; Sun Y; Jin T; Zhu P; Wan X; Hou Y; Tu G
J Exp Clin Cancer Res; 2021 May; 40(1):168. PubMed ID: 33990217
[TBL] [Abstract][Full Text] [Related]
19. Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation.
Tsolou A; Koparanis D; Lamprou I; Giatromanolaki A; Koukourakis MI
Int J Radiat Biol; 2023; 99(4):692-701. PubMed ID: 35976051
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the human skeletal muscle glycogen synthase gene (GYS1) promoter.
Fredriksson J; Ridderstråle M; Groop L; Orho-Melander M
Eur J Clin Invest; 2004 Feb; 34(2):113-21. PubMed ID: 14764074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
